Announce Date | 05/01/2025 |
EPS Normalized Actual | $0.13 (Miss by $-0.12) |
EPS GAAP Actual | $0.13 (Miss by $-0.12) |
Revenue Actual | $0.483521B |
Revenue Surprise | Beat by $483.521M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.405 |
EPS GAAP Estimate | $2.405 |
Revenue Estimate | $0.6440605B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2027 | 4.6 | 3.37 | 4.51663 | 4.67757 | 2 |
Sep 2026 | 5.33 | 2.91 | 5.18348 | 5.53061 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.02 | -0.825 | 0.483521B | -0.99% | -27.97M |
FQ4 2024 (Dec 2024) | -0.81 | -0.81 | 0.375814B | 3.14% | 375.81M |
FQ3 2024 (Sep 2024) | -0.634 | -0.634 | 0.377855B | -19.35% | 377.86M |
FQ4 2017 (Dec 2017) | -110.66 | -110.66 | 0.110826B | 100% | 110.83M |
FQ1 2018 (Mar 2018) | -110.66 | -110.66 | 0.110826B | 100% | 110.83M |
FQ2 2024 (Jun 2024) | 1.01 | 1.01 | 0.542441B | -9.57% | 542.44M |
FQ1 2024 (Mar 2024) | -0.27 | -0.27 | 0.488321B | -7.37% | 488.32M |
FQ4 2023 (Dec 2023) | -0.49 | -0.49 | 0.364013B | 100% | 364.01M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
2.405
Consensus Revenue Estimates
0.6440605B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 2.54 | -- | 2.43883 | 2.67063 | 3 |
FQ1 2027 (Mar 2027) | 1.24 | -- | 1.19061 | 1.30377 | 3 |
FQ4 2026 (Oct 2026) | 1.259 | -- | 1.24622 | 1.26942 | 0 |
FQ3 2026 (Jul 2026) | 2.8955 | -- | 2.86611 | 2.91946 | 0 |
FQ2 2026 (Jun 2026) | 2.8955 | -- | 2.78492 | 3.07236 | 3 |
FQ1 2026 (Mar 2026) | 1.2873 | 101.55 | 1.23814 | 1.36593 | 3 |
FQ4 2025 (Oct 2025) | 0.935 | 186.63 | 0.91666 | 0.95703 | 1 |
FQ3 2025 (Jul 2025) | 2.37 | 126.75 | 2.32351 | 2.42584 | 1 |
FQ2 2025 (Jun 2025) | 2.405 | 58 | 2.29002 | 2.48315 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 0.62B | -- | 0.6B | 0.65B | 4 |
FQ1 2027 (Mar 2027) | 0.53B | -- | 0.51B | 0.55B | 4 |
FQ4 2026 (Oct 2026) | 0.88B | -- | 0.87B | 0.89B | 2 |
FQ3 2026 (Jul 2026) | 0.83B | -- | 0.82B | 0.84B | 2 |
FQ2 2026 (Jun 2026) | 0.87B | -- | 0.84B | 0.91B | 4 |
FQ1 2026 (Mar 2026) | 0.82B | 41 | 0.8B | 0.86B | 4 |
FQ4 2025 (Oct 2025) | 0.48B | 21.15 | 0.47B | 0.49B | 0 |
FQ3 2025 (Jul 2025) | 0.63B | 40.41 | 0.62B | 0.65B | 0 |
FQ2 2025 (Jun 2025) | 0.64B | 15.78 | 0.62B | 0.66B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.805 | -0.02 | -0.825 | 4125% |
FQ4 2024 (Dec 2024) | -0.81 | -0.81 | 100% | |
FQ3 2024 (Sep 2024) | -0.634 | -0.634 | 100% | |
FQ4 2017 (Dec 2017) | -110.66 | -110.66 | 100% | |
FQ1 2018 (Mar 2018) | -110.66 | -110.66 | 100% | |
FQ2 2024 (Jun 2024) | 1.01 | 1.01 | 100% | |
FQ1 2024 (Mar 2024) | -0.27 | -0.27 | 100% | |
FQ4 2023 (Dec 2023) | -0.49 | -0.49 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.51B | $0.48B | $-27.97M | -5.78% |
FQ4 2024 (Dec 2024) | $0B | $0.38B | $375.81M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.38B | $377.86M | 100% |
FQ4 2017 (Dec 2017) | $0B | $0.11B | $110.83M | 100% |
FQ1 2018 (Mar 2018) | $0B | $0.11B | $110.83M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.54B | $542.44M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.49B | $488.32M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.36B | $364.01M | 100% |